|
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India |
Jan 11 2016 |
235 |
India |
$1,995.00 |
|
|
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia |
Feb 1 2016 |
178 |
Indonesia |
$1,995.00 |
|
|
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia |
Jul 1 2016 |
238 |
Saudi Arabia |
$1,995.00 |
|
|
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK |
Mar 1 2016 |
253 |
United Kingdom |
$1,995.00 |
|
|
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam |
Jul 1 2016 |
147 |
Vietnam |
$1,995.00 |
|
|
Frontier Pharma: Obesity - Identifying and Commercializing First-in-Class Innovation |
Oct 1 2015 |
87 |
Global |
$6,995.00 |
|
|
Gastric and Gastroesophageal Junction Adenocarcinoma - 5EU Drug Forecast and Market Analysis to 2024 |
Dec 9 2015 |
283 |
Europe |
$6,995.00 |
|
|
Gastric and Gastroesophageal Junction Adenocarcinoma - China Drug Forecast and Market Analysis to 2024 |
Dec 9 2015 |
270 |
China |
$4,995.00 |
|
|
Gastric and Gastroesophageal Junction Adenocarcinoma - Current and Future Players |
Dec 9 2015 |
122 |
Global |
$2,995.00 |
|
|
Gastric and Gastroesophageal Junction Adenocarcinoma - Japan Drug Forecast and Market Analysis to 2024 |
Dec 9 2015 |
269 |
Japan |
$4,995.00 |
|
|
Gastric and Gastroesophageal Junction Adenocarcinoma - US Drug Forecast and Market Analysis to 2024 |
Dec 9 2015 |
267 |
USA |
$4,995.00 |
|
|
Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design |
Mar 1 2017 |
117 |
Global |
$2,995.00 |
|
|
Hemophilia A and B Recombinant Factor Replacement Therapy - 5EU Drug Forecast and Market Analysis to 2024 |
Dec 11 2015 |
242 |
Europe |
$6,995.00 |
|
|
Hemophilia A and B Recombinant Factor Replacement Therapy - Argentina Drug Forecast and Market Analysis to 2024 |
Dec 11 2015 |
229 |
Argentina |
$4,995.00 |
|
|
Hemophilia A and B Recombinant Factor Replacement Therapy - Current and Future Players |
Dec 11 2015 |
84 |
Global |
$2,995.00 |
|
|
Hemophilia A and B Recombinant Factor Replacement Therapy - Japan Drug Forecast and Market Analysis to 2024 |
Dec 11 2015 |
229 |
Japan |
$4,995.00 |
|
|
Hemophilia A and B Recombinant Factor Replacement Therapy - US Drug Forecast and Market Analysis to 2024 |
Dec 11 2015 |
229 |
USA |
$4,995.00 |
|
|
Methicillin-Resistant Staphylococcus aureus (MRSA) - 5EU Drug Forecast and Market Analysis to 2024 |
Dec 16 2015 |
328 |
Europe |
$6,995.00 |
|
|
Methicillin-Resistant Staphylococcus aureus (MRSA) - Current and Future Players |
Dec 16 2015 |
125 |
Global |
$2,995.00 |
|
|
Methicillin-Resistant Staphylococcus aureus (MRSA) - Japan Drug Forecast and Market Analysis to 2024 |
Dec 16 2015 |
321 |
Japan |
$4,995.00 |
|
|
Methicillin-Resistant Staphylococcus aureus (MRSA) - US Drug Forecast and Market Analysis to 2024 |
Dec 16 2015 |
320 |
USA |
$4,995.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2016 in Pharmaceuticals |
Jun 1 2016 |
98 |
Global |
$1,000.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends for December 2015 in Pharmaceuticals |
Feb 1 2016 |
99 |
Global |
$1,000.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends for January 2016 in Pharmaceuticals |
Mar 1 2016 |
108 |
Global |
$1,000.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends for March 2016 in Pharmaceuticals |
May 1 2016 |
97 |
Global |
$1,000.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends for May 2016 in Pharmaceuticals |
Jul 1 2016 |
93 |
Global |
$1,000.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends for October 2015 in Pharmaceuticals |
Dec 1 2015 |
100 |
Global |
$1,000.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2016 |
Jun 3 2016 |
132 |
Global |
$1,500.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015 |
Feb 11 2016 |
148 |
Global |
$1,500.00 |
|
|
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016 |
Apr 1 2017 |
111 |
Global |
$1,500.00 |
|
